Share Precision Prostate Cancer Diagnostics and Treatments with your friends. Share The Diagnosis and Treatment of Tourette Syndrome with your friends. Finally, the system offers thermal protection of important anatomy (i.e., urethra and rectum cooling). [Content_Types].xml ( 0+V$$mziH} 7HbC V}09_3&VPMYVE:=! Southwest Prostate Cancer Symposium. 10/23/2022 - 10/25/2022. The Genitourinary (GU) Cancer Committee of the Southwestern OncologyGroup (SWOG) has achieved repeated successes in conducting prospective studies of prostatecancer. . 8:00 a.m. - 8:30 a.m. Check In and Breakfast. Genetics: Risk-based Screening and Hereditary Prostate Cancer, Earlier and Combined: New Treatment Paradigms, Patient Centered Pathology Reports; Present and Future Microscopy, Radiation Therapy: Expanding the Opportunities. Save Breast Cancer: Innovative Cancer Treatment and Research at UVA (virtual) to your collection. 10:45 a.m. Radiation Therapy Expanding the Opportunities | Emily Weg, M.D. Southwest Prostate Cancer Symposium 2023 March 9, 2023 Events Westin Kierland Resort Scottsdale, Arizona We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. Southwest Prostate Cancer Symposium 12/9/2021 - 12/11/2021 Hosted by: Grand Rounds in Urology Event Website Scottsdale, AZ Westin Kierland Resort Will you be attending this event? :
$MGvZ5?'elw-f6Z?X 'H^haYX H{q^Xah"Z&rh"ZW&rh"aR? The goal of this educational program is to equip urologists, radiation oncologists, medical oncologists, and other healthcare professionals involved in prostate cancer care with the up-to-date clinical knowledge and tools they need to best treat their patients. The Southwest Prostate Cancer Symposium (SPCS 2024) is intended for urologists, radiation oncologists, medical oncologists, and other healthcare professionals involved in the treatment of prostate cancer. 9th Annual Moyad and Scholz Free for All! February 17, 2022. How does one explain the different outcomes? 9/25/2021. Thus, controversy continues to rage over the benefit of total androgenblockade. Can We Make Low-Fat Foods More Palatable? H($3}br MERa(*"#sVWDa9Ix|Jr$
:s,AO&WU#nXD
xB8/Hu*#Wj 6q?-sk+@eyBeBXU
tc0T? B?t/em3mhss^['xcu+\['xo G}[bd#7F1}w#e
S:_[v=!UY-t4q;!UdtH~p'%h_uO$NG70ccLf|
d1qLf It is a 4 day event organised by Carden Jennings Publishing Co., Ltd and will conclude on 16-Apr-2023. Our thanks to the generous supporters who helped raise $2.1 million (and still counting) in the fight against prostate cancer! Also, this year included a hands- on lab tour. Read an article about the eventhere, and view the symposium presentations. We understand that you have many questions, and we can help you find the answers that are specific to your case. Doctors & Clinicians. Prostate cancer is the most common cancer among males (27%), followed by lung (12%) and colorectal (8%) cancers. The efficacy and safety of Lynparza in combination with abiraterone and prednisone or prednisolone have been demonstrated in the PROpel Phase III trial, first presented at the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), and subsequently published in the New England Journal of Medicine Evidence. All rights reserved. He outlines the key features of the TULSA system, explaining that it delivers transurethral directional ultrasound ablation which is incision and radiation free, and there is no energy coming through the rectum and there is no volume limitation. CLICK THE VIDEO TO LEARN ABOUT OUR PROGRAMS. *Please note, this broadcast will remain posted here indefinitely and on our YouTube channel for viewing after the broadcast is over.
Southwest Oncology Group Studies Vitamin E, Selenium to Prevent Any Question on Any Aspect of Prostate Cancer!
Exhibitions and Events Gold Anchor We are an Affirmative Action employer. Dr. Taneja then considers the benefits of imaging post partial gland ablation, explaining that very early imaging evaluates the anatomy of ablation but not its efficacy, intermediate interval imaging guides biopsy and identifies need for retreatment, delayed imaging identifies recurrence. The principal nature of a specific physicians relationship is disclosed on this website adjacent to language featuring that physician.
PHS290 May Help Predict Lifetime Risk of Metastatic or Fatal Prostate Amongfemales, breast (31%), lung (13%), and colorectal (8%) cancers are the most common. Dr. Klotz lists prospective studies of focal therapy that found relatively few adverse quality-of-life (QOL) effects. Oncology Peer Review On-The-Go: Efficacy of PARP Inhibitors as Maintenance Therapy for Metastatic Castration-Resistant Prostate Cancer. Disclosure: The physicians featured on this website may have prior or current relationships with Isoray. He also focuses on metastatic, hormone-sensitive prostate cancer (mHSPC) and concludes that upfront treatment with either abiraterone + prednisone, apalutamide, enzalutamide, or docetaxel is the standard of care and he asserts that new evidence from PEACE-1 and ARASENS supports triple therapy with a novel hormonal therapy +ADT+docetaxel for chemotherapy patients. Location.
Register for #SPCS2021 and enjoy - Grand Rounds In Urology - Facebook This day-long event is filled with scientific insights and projections, discussions on technology and patient care, reviews of the latest scientific innovations and landmark research projects changing how scientists view this disease. At the end of the conference, Drs.
One sincerely hopes that the SWOG8794 adjuvant radiation trial will serve as an example to funding agenciesof the importance of maintaining organizations that are willing and ableto tackle the tough scientific questions in oncology, whether or not theyare of interest to the pharmaceutical industry. 11:15 a.m. Patient Centered Research: Why adn How | Marty Chakoian, 11:30 a.m. Q&A, 11:45 a.m. - 1:00 p.m. Lunch & Activities, 11:55 a.m. - 1:00 p.m. BACPAC Group Breakout Session. Dr. Klotz explains the challenges involved in demonstrating level-one evidence for the benefit of new technologies since benefits tend to be incremental and gradual. For focal therapy, Dr. Stone advocates for what he calls a unified approach using TPMB, which can be done under local anesthesia.
Southwest Prostate Cancer Symposium 2023 - Perspective Therapeutics The limitations of meta-analysis are well known. Denise Castetter, Senior Director of Corporate Relations. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. Copyright 2023 Carden Jennings Publishing Co., Ltd. All Rights Reserved. Meeting Room. Save The Diagnosis and Treatment of Tourette Syndrome to your collection. He describes the TULSA-PRO Ablation Clinical Trial (TACT), which involved 115 patients across 13 institutions in five countries, with safety (frequency/severity of adverse events) and efficacy (PSA reduction 75 percent in >50 percent of patients) being the primary endpoints at 12 months. Or maybe we already met some of your colleagues? February 18, 2022. It is estimated that more than 1.9 million new cases of cancer will be diagnosed in 2022. Oncology Peer Review On-The-Go: Successful Diagnosis and Treatment of Occult Prostate Cancer Despite Multiple Negative Prostate Biopsies and Negative Prostate MRIs. [5,6] In the absence of a comparative trial,no conclusions could be reached about the impact of this therapy on disease-specificsurvival. Share Everyones Problem: Inequity in Diagnosis and Treatment with your friends. The Genitourinary (GU) Cancer Committee of the Southwestern Oncology Group (SWOG) has achieved repeated successes in conducting prospective studies of prostate cancer. AdMeTech Foundation's 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer is a unique multidisciplinary educational forum. The motivation to accrue came largelyfrom a desire by participants to answer this important scientific question.The results of this trial (to which accrual closed in December 1996) willhave a major effect on the management of patients with positive margins. 6:45 AM - 7:45 AM Educational Meeting. Register Today Save Precision Prostate Cancer Diagnostics and Treatments to your collection. 2023 edition of Southwest Prostate Cancer Symposium will be held at The Westin Kierland Resort & Spa, Scottsdale starting on 13th April. Nurse Practitioners/Physician's Assistants, 2022 ASCO Genitourinary Cancers Symposium Urothelial Cancer Updates, Contemporary Concepts in Hematologic Oncology, Insights from Experts at Mayo Clinic on Translating Evidence to Clinical Practice, Optimizing Outcomes in Patients with HER2+ Metastatic Breast Cancer. Urology Conferences, Meetings, and CME. Samir S. Taneja, MD, the James M. Neissa and Janet Riha Neissa Professor of Urologic Oncology, Co-Director of the Smilow Comprehensive Prostate Cancer Center, and Vice Chair of the Department of Urology at NYU Grossman School of Medicine, discusses how to use MRI in planning and doing follow-up on focal therapy for prostate cancer. 11:00 a.m. Survivorship Improving Treatment Outcomes | Judith Hagedorn, M.D.
Update on US regulatory review of Lynparza in combination with Another noteworthy SWOG accomplishment is the development of the GUGlobal Group. Since 2016, it has brought together the key international opinion leaders of every clinical subspecialty involved in patient care. 19. Copyright 2023 Carden Jennings Publishing Co., Ltd. All Rights Reserved.
PPTX PowerPoint Presentation Posted by Thomas J. Polascik, MD, FACS | Jul 2022. Many of these physicians have received or continue to receive compensation from Isoray in one form or another. Patients & Families. 11 people interested. | Mark Moyad, MD & Mark Scholz, MD. Given the prevalence of prostate cancer, and the societal costs, thereis no excuse for not carrying out large randomized trials to address thefundamental questions that clinicians face. 29th Annual Perspectives in Urology: Point Counterpoint.
PDF Nyu Winthrop Department of Radiation Oncology Sbrt for Prostate Cancer The SWOG 8794 study of adjuvant radiotherapy vs observation followingradical prostatectomy in patients with positive margins represents a tremendousaccomplishment. He begins by displaying a chart of multiple minimally invasive treatment options for prostate cancer. 2. Feel free to explore our website or call us at 1 (800)641-7274 with any question that you have. Save Fitness at Diagnosis, Treatment, and After Treatment to your collection. [4] Both overall and disease-specificsurvival were improved in the immediate-treatment group. Racial disparities in prostate cancer time to make a difference, Dr. Ruth Etzioni, Inherited Risk: GENTleMEN, Dr. Heather Cheng, Diet and Prostate Cancer, Dr. Marian Neuhouser, Exercise Interventions and Prostate Cancer, Dr. Jonathan Wright, Enhancing Quality of Life, Dr. Niels Johnsen, Prostate Cancer: Disparity, Risk and Quality of Life Q & A, The New Pathology (Light Sheet). 8:30 a.m. Introduction | Pete Nelson, M.D. Meeting organized byGrand Rounds in Urology, a division of Carden Jennings Publishing, Co., Ltd. Jointly provided by Medical Education Resources and Carden Jennings Publishing Co., Ltd. Many of these physicians have received or continue to receive compensation from Isoray in one form or another. He begins by introducing the critical decisions in focal therapy implementation, including candidate selection, method of disease mapping/identification, choice of energy, and manner of follow-up/verification of efficacy. These relationships may include, for example: membership on Isorays Advisory Board; participation as a clinical investigator in research conducted on Isoray products; provision of consultation or training services; or engagement as a prospective partner in the development of new products. Radium-223 Can Be Integrated into Treatment Sequencing in Metastatic CRPC. 2022 ASCO Genitourinary Cancers Symposium arrow_drop_down. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class.
Urology Conferences, Meetings, and CME | MDLinx The Southwest Prostate Cancer Symposium (SPCS 2023) is intended for urologists, radiation oncologists, medical oncologists, and other healthcare professionals involved in the treatment of prostate cancer.Join us for IPCU 33 January 22-25, 2023 Grand Rounds in Urology 02:31 Agenda The International Prostate Cancer Update offers a comprehensive . Ed1-qLfM jP.z& @B6P. This trial was hard to sell to patients. Will Current Clinical Trials Answer the Most Important Questions About Prostate Adenocarcinoma? It is unique because of itslarge size (about 1,300 patients). 2022 IPCR Symposium 2021 IPCR Symposium 2019 IPCR Symposium 2018 IPCR Symposium Survivors' Celebration Breakfast Dr. Bruce Montgomery speaks about genome-guided therapy in advanced prostate cancer The 4th Annual IPCR Symposium was held at the Fred Hutch campus in Seattle, Wash. on Saturday, April 11, 2015. Read the Know your Rights: Workplace Discrimination is Illegal Poster. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans.
SW Prostate Cancer Foundation Pacific Northwest Prostate Cancer Conference - OHSU Aconcerted effort by senior trial investigators to promote and publicizethe trial, and to bring in contributors throughout North America, resultedin its eventual successful accrual. He goes on to compare five ultrasound-based technologies in terms of biopsy and prostate-specific antigen (PSA) outcome, concluding that data demonstrates these therapies work.
Institute for Prostate Cancer Research Events - Fred Hutch Weve built a social media toolkit to help you spread the word about the meeting to your friends and colleagues. This study, perhaps more than any other, illustrates the importanceof cooperative clinical trials groups in furthering our ability to practiceevidence-based medicine. To inquire about support opportunities, please contact: Denise Castetter, Senior Director of Corporate RelationsCell: 973-769-1020Fax: 434-817-2020 dcastetter@cjp.com. Advanced Prostate Cancer Consensus Conference (APCCC) Save the Date 25 - 27 April 2024 Lugano / Switzerland . Scottsdale, USA Website Exhibited In May 2016 WoItes Kiuwer Healm Baltimore, USA Website Renowned physicians from different specialties will be covering topics including advanced cancer, active surveillance, radiation treatment, imaging, erectile dysfunction, and incontinence. He cites the da Vinci robot as an important example and explains that the U.S. Food and Drug Administration (FDA) has acknowledged this in its approval of high intensity focused ultrasound (HIFU) and TULSA (for tissue ablation). He explains that treating a single quadrant as identified by MRI may leave unidentified clinically-significant prostate cancer behind. Save Novel Testing to Guide Personalized Cancer Treatment to your collection. Grand Ballroom (Level 2) This event will also be webcast live. This trial is of landmark importance.It represents the 27th randomized prospective trial of total androgen blockadecompared to monotherapy performed since 1979. All of these questionswill require further studies. Save Prostate Cancer diagnosed less than 12 months ago to your collection.
2022 Prostate Cancer Patient Conference k Q _rels/.rels ( J1mizY`Hfn2$ooDjc&0OScj0\c-;0Y)xb`Gk)WQ8.SBzM]bf4{o!
(| ;v!xI*hFgV.&>8'-?6"8W[ PK ! Thu. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. It requireda concerted effort on the part of hundreds of physicians. In this 21-minute presentation, Thomas J. Polascik, MD, FACS, Professor of Surgery at Duke University and Director of Surgical Technology at the Duke Prostate and Urological Cancer Center, posits that patients discontinuing active surveillance (AS) for prostate cancer may be good candidates for focal therapy (FT) rather than radical therapy, describing an international Delphi Consensus on the issue. Can these individuals be identifiedusing genetic markers, for example? Further, real-time MRI thermal dosimetry and ablation control means temperature is measured in real time and the system adjusts the amount of energy delivered to the tissue, providing precision, actively compensating for tissue and blood flow changes during the treatment. Precision Prostate Cancer Diagnostics and Treatments, Fitness at Diagnosis, Treatment, and After Treatment, Prostate Cancer diagnosed less than 12 months ago, Everyones Problem: Inequity in Diagnosis and Treatment, The Diagnosis and Treatment of Tourette Syndrome, Recording of Navigating Diagnostic and Treatment Challenges Conference, NCLEX Review - Med/Surg Comprehensive Diagnosis, Treatment, & Pharm, Novel Testing to Guide Personalized Cancer Treatment, Breast Cancer: Innovative Cancer Treatment and Research at UVA (virtual).
Pi Rads 4 Lesion Prostate - ProstateProHelp.com 8:45 a.m. Risk Based Screening and Hereditary Prostate Cancer | Heather Chung, M.D., Ph.D. 9:00 a.m. Polygenic Risk | Burcu Darst, Ph.D. 9:15 a.m. Prostate Cancer Disparities | Yaw Nyame, M.D., M.S., M.B.A. 9:30 a.m. Patient -Centered Pathology Reports: PSMA Imaging | Larry True, M.D.
Does Hard Water Cause Permanent Hair Loss,
Kadee 5 Couplers Bulk Pack,
Sigvaris Compression Stockings 15-20 Mmhg,
Non Slip Boat Flooring Paint,
What Is Reevaluating Outsourcing,
Intersect Cam Lock Generator Connector,
Henry Norman Hotel Parking,